ATE274341T1
(de)
*
|
1995-02-24 |
2004-09-15 |
Elan Pharma Int Ltd |
Nanopartikel-dispersionen enthaltende aerosole
|
US6465016B2
(en)
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
US20050004049A1
(en)
*
|
1997-03-11 |
2005-01-06 |
Elan Pharma International Limited |
Novel griseofulvin compositions
|
CN1245955C
(zh)
|
1998-05-29 |
2006-03-22 |
斯凯伊药品加拿大公司 |
热保护微粒组合物及其最终蒸汽灭菌的方法
|
US8293277B2
(en)
*
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
US20080213378A1
(en)
*
|
1998-10-01 |
2008-09-04 |
Elan Pharma International, Ltd. |
Nanoparticulate statin formulations and novel statin combinations
|
US8236352B2
(en)
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
US20090297602A1
(en)
*
|
1998-11-02 |
2009-12-03 |
Devane John G |
Modified Release Loxoprofen Compositions
|
IL142896A0
(en)
|
1998-11-02 |
2002-04-21 |
Elan Corp Plc |
Multiparticulate modified release composition
|
US20040141925A1
(en)
*
|
1998-11-12 |
2004-07-22 |
Elan Pharma International Ltd. |
Novel triamcinolone compositions
|
US6428814B1
(en)
*
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
JP4809533B2
(ja)
|
1998-11-20 |
2011-11-09 |
オバン・エナジー・リミテッド |
分散し得るリン脂質で安定化されたミクロ粒子
|
KR100801588B1
(ko)
*
|
1999-09-21 |
2008-02-05 |
스키에파마 캐나다 인코포레이티드 |
생물학적 유효 물질의 표면 변형된 미립자 조성물
|
US6770478B2
(en)
*
|
2000-02-10 |
2004-08-03 |
The Regents Of The University Of California |
Erythrocytic cells and method for preserving cells
|
US7198795B2
(en)
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
US20030224058A1
(en)
*
|
2002-05-24 |
2003-12-04 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US7998507B2
(en)
*
|
2000-09-21 |
2011-08-16 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
US20050048126A1
(en)
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
US20040256749A1
(en)
*
|
2000-12-22 |
2004-12-23 |
Mahesh Chaubal |
Process for production of essentially solvent-free small particles
|
US7037528B2
(en)
*
|
2000-12-22 |
2006-05-02 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
US20030096013A1
(en)
*
|
2000-12-22 |
2003-05-22 |
Jane Werling |
Preparation of submicron sized particles with polymorph control
|
US7193084B2
(en)
*
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
US7053092B2
(en)
|
2001-01-29 |
2006-05-30 |
Otsuka Pharmaceutical Co., Ltd. |
5-HT1a receptor subtype agonist
|
US20040126900A1
(en)
*
|
2001-04-13 |
2004-07-01 |
Barry Stephen E |
High affinity peptide- containing nanoparticles
|
EP1389462B1
(fr)
*
|
2001-04-26 |
2012-06-06 |
Meiji Seika Pharma Co., Ltd. |
Composition de cefditoren pivoxil amorphe et procede de fabrication correspondant
|
US6976647B2
(en)
*
|
2001-06-05 |
2005-12-20 |
Elan Pharma International, Limited |
System and method for milling materials
|
ATE291899T1
(de)
*
|
2001-06-22 |
2005-04-15 |
Marie Lindner |
Screening-verfahren mit hohem durchsatz (hts) unter verwendung von labormühlen oder microfluidics
|
US7758890B2
(en)
|
2001-06-23 |
2010-07-20 |
Lyotropic Therapeutics, Inc. |
Treatment using dantrolene
|
US20050009908A1
(en)
*
|
2001-08-06 |
2005-01-13 |
Hedberg Pia Margaretha Cecilia |
Aqueous dispersion comprising stable nonoparticles of a water-insoluble active and an excipient like middle chain triglycerides (mct)
|
US20030054042A1
(en)
*
|
2001-09-14 |
2003-03-20 |
Elaine Liversidge |
Stabilization of chemical compounds using nanoparticulate formulations
|
PT1429731E
(pt)
*
|
2001-09-19 |
2007-04-30 |
Elan Pharma Int Ltd |
Formulações de insulina nanoparticulada
|
US8703772B2
(en)
|
2001-09-25 |
2014-04-22 |
Otsuka Pharmaceutical Co., Ltd. |
Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
|
AR033485A1
(es)
|
2001-09-25 |
2003-12-26 |
Otsuka Pharma Co Ltd |
Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
|
US20060003012A9
(en)
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
MXPA04002446A
(es)
|
2001-09-26 |
2004-07-23 |
Baxter Int |
Preparacion de nanoparticulas de tamano de submicras mediante dispersion y remocion de la fase liquida o solvente.
|
PT1443912E
(pt)
*
|
2001-10-12 |
2007-11-28 |
Elan Pharma Int Ltd |
Composições tendo uma combinação de características de libertação imediata e de libertação controlada
|
AU2002362836B2
(en)
*
|
2001-10-15 |
2008-05-22 |
Crititech, Inc. |
Compositions and methods for delivery of poorly water soluble drugs and methods of treatment
|
US7112340B2
(en)
*
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
UA76810C2
(uk)
*
|
2001-12-10 |
2006-09-15 |
Мерк Енд Ко., Інк. |
Фармацевтична композиція антагоніста рецептора тахікініну у формі наночастинок
|
US20030129242A1
(en)
*
|
2002-01-04 |
2003-07-10 |
Bosch H. William |
Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
|
JP4598399B2
(ja)
*
|
2002-02-04 |
2010-12-15 |
エラン ファーマ インターナショナル,リミティド |
表面安定剤としてリゾチームを有するナノ粒子組成物
|
US20040101566A1
(en)
*
|
2002-02-04 |
2004-05-27 |
Elan Pharma International Limited |
Novel benzoyl peroxide compositions
|
JP4842514B2
(ja)
*
|
2002-03-20 |
2011-12-21 |
エラン ファーマ インターナショナル,リミティド |
血管新生抑制剤のナノ粒子組成物
|
EP1800666A1
(fr)
*
|
2002-03-20 |
2007-06-27 |
Elan Pharma International Limited |
Compositions nanoparticulaires d'inhibiteurs d'angiogenese
|
EP2263650A3
(fr)
|
2002-04-12 |
2013-12-25 |
Alkermes Pharma Ireland Limited |
Formulations de mégestrol nanoparticulaire
|
US7101576B2
(en)
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
US20040105889A1
(en)
*
|
2002-12-03 |
2004-06-03 |
Elan Pharma International Limited |
Low viscosity liquid dosage forms
|
US9101540B2
(en)
*
|
2002-04-12 |
2015-08-11 |
Alkermes Pharma Ireland Limited |
Nanoparticulate megestrol formulations
|
US20100226989A1
(en)
*
|
2002-04-12 |
2010-09-09 |
Elan Pharma International, Limited |
Nanoparticulate megestrol formulations
|
US20040018242A1
(en)
*
|
2002-05-06 |
2004-01-29 |
Elan Pharma International Ltd. |
Nanoparticulate nystatin formulations
|
CA2488498A1
(fr)
*
|
2002-06-10 |
2003-12-18 |
Elan Pharma International Limited |
Formulation de polycosanol nanoparticulaires et nouvelles combinaisons de polycosanol
|
AU2003261167A1
(en)
*
|
2002-07-16 |
2004-02-02 |
Elan Pharma International, Ltd |
Liquid dosage compositions of stable nanoparticulate active agents
|
ES2355723T3
(es)
|
2002-09-11 |
2011-03-30 |
Elan Pharma International Limited |
Composiciones de agente activo en nanopartículas estabilizadas en gel.
|
CA2500908A1
(fr)
*
|
2002-10-04 |
2004-04-22 |
Elan Pharma International Limited |
Irradiation gamma d'agents actifs nanoparticulaires solides
|
AU2003297260A1
(en)
*
|
2002-11-12 |
2004-06-03 |
Elan Pharma International Ltd. |
Fast-disintegrating solid dosage forms being not friable and comprising pullulan
|
CN1243538C
(zh)
*
|
2002-11-21 |
2006-03-01 |
武汉利元亨药物技术有限公司 |
熊果酸豆磷脂纳米粒冻干粉针及制备方法
|
WO2004058216A2
(fr)
*
|
2002-12-17 |
2004-07-15 |
Elan Pharma International Ltd. |
Broyage de quantites de composes candidats nanoparticulaires de l'ordre du microgramme
|
EP1587499A1
(fr)
*
|
2003-01-31 |
2005-10-26 |
Elan Pharma International Limited |
Formulations contenant des nanoparticules de topiramate
|
US20040208833A1
(en)
*
|
2003-02-04 |
2004-10-21 |
Elan Pharma International Ltd. |
Novel fluticasone formulations
|
US8512727B2
(en)
*
|
2003-03-03 |
2013-08-20 |
Alkermes Pharma Ireland Limited |
Nanoparticulate meloxicam formulations
|
US20100297252A1
(en)
|
2003-03-03 |
2010-11-25 |
Elan Pharma International Ltd. |
Nanoparticulate meloxicam formulations
|
WO2004105809A1
(fr)
*
|
2003-05-22 |
2004-12-09 |
Elan Pharma International Ltd. |
Sterilisation de dispersions d'agents actifs particulaires au moyen de rayons gamma
|
US20050042177A1
(en)
*
|
2003-07-23 |
2005-02-24 |
Elan Pharma International Ltd. |
Novel compositions of sildenafil free base
|
WO2005016310A1
(fr)
*
|
2003-08-08 |
2005-02-24 |
Elan Pharma International Ltd. |
Nouvelles compositions de metaxalone
|
NZ545744A
(en)
*
|
2003-09-22 |
2009-12-24 |
Baxter Int |
High-pressure sterilization to terminally sterilize pharmaceutical preparations and medical products
|
ATE411797T2
(de)
|
2003-10-23 |
2008-11-15 |
Otsuka Pharma Co Ltd |
Sterile injizierbare aripiprazol-formulierung mit kontrollierter freisetzung und verfahren
|
TWI371274B
(en)
*
|
2003-10-23 |
2012-09-01 |
Bristol Myers Squibb Co |
Process for making sterile aripiprazole of desired mean particle size
|
CA2544627A1
(fr)
*
|
2003-11-05 |
2005-05-19 |
Elan Pharma International Ltd. |
Compositions nanoparticulaires comprenant un peptide comme stabilisant de surface
|
EP1711163A2
(fr)
*
|
2004-02-05 |
2006-10-18 |
Baxter International Inc. |
Dispersions preparees avec des agents autostabilisants
|
GB0410995D0
(en)
|
2004-05-17 |
2004-06-23 |
Norton Healthcare Ltd |
Heat sterilization of glucocorticosteroids
|
US20060083694A1
(en)
|
2004-08-07 |
2006-04-20 |
Cabot Corporation |
Multi-component particles comprising inorganic nanoparticles distributed in an organic matrix and processes for making and using same
|
WO2006083326A2
(fr)
|
2004-08-07 |
2006-08-10 |
Cabot Corporation |
Fabrication d'une dispersion gazeuse de nanoparticules, et produits contenant des nanoparticules et traitement de ceux-ci
|
CA2577583A1
(fr)
*
|
2004-08-19 |
2006-03-02 |
Alza Corporation |
Formes posologiques renfermant une formulation d'agent actif nanoparticulaire a liberation retardee et procedes
|
ES2526092T3
(es)
*
|
2004-11-16 |
2015-01-05 |
Alkermes Pharma Ireland Limited |
Formulaciones de olanzapina en nanopartículas inyectables
|
UA89513C2
(uk)
*
|
2004-12-03 |
2010-02-10 |
Элан Фарма Интернешнл Лтд. |
Стабільна композиція з наночастинок ралоксифену гідрохлориду
|
US20080145430A1
(en)
*
|
2004-12-08 |
2008-06-19 |
Santipharp Panmai |
Ophthalmic Nanoparticulate Formulation Of A Cyclooxygenase-2 Selective Inhibitor
|
CA2590675A1
(fr)
*
|
2004-12-15 |
2006-06-22 |
Elan Pharma International Ltd. |
Formulations renfermant des nanoparticules de tacrolimus
|
WO2006069098A1
(fr)
*
|
2004-12-22 |
2006-06-29 |
Elan Pharma International Ltd. |
Formulations de la bicalutamide nanoparticulaire
|
JP2008526855A
(ja)
*
|
2005-01-06 |
2008-07-24 |
エラン ファーマ インターナショナル リミテッド |
ナノ粒子のカンデサルタン製剤
|
AU2006214443C1
(en)
*
|
2005-02-15 |
2011-11-24 |
Alkermes Pharma Ireland Limited |
Aerosol and injectable formulations of nanoparticulate benzodiazepine
|
JP2008531721A
(ja)
*
|
2005-03-03 |
2008-08-14 |
エラン・ファルマ・インターナショナル・リミテッド |
複素環式アミド誘導体のナノ粒子状組成物
|
US20060204588A1
(en)
*
|
2005-03-10 |
2006-09-14 |
Elan Pharma International Limited |
Formulations of a nanoparticulate finasteride, dutasteride or tamsulosin hydrochloride, and mixtures thereof
|
EP1863450A1
(fr)
*
|
2005-03-16 |
2007-12-12 |
Elan Pharma International Limited |
Formulations nanoparticulaires d'un antagoniste du recepteur de leukotriene/d'un corticosteroide
|
EP1865928A1
(fr)
*
|
2005-03-17 |
2007-12-19 |
Elan Pharma International Limited |
Compositions de biphosphanate nanoparticulaires
|
AU2006226887A1
(en)
*
|
2005-03-23 |
2006-09-28 |
Elan Pharma International Limited |
Nanoparticulate corticosteroid and antihistamine formulations
|
AU2006235487B2
(en)
*
|
2005-04-12 |
2011-12-22 |
Elan Pharma International Limited |
Nanoparticulate quinazoline derivative formulations
|
JP2008535921A
(ja)
|
2005-04-12 |
2008-09-04 |
エラン・ファルマ・インターナショナル・リミテッド |
シクロスポリンを含むナノ粒子および放出調節された組成物
|
US20060246141A1
(en)
*
|
2005-04-12 |
2006-11-02 |
Elan Pharma International, Limited |
Nanoparticulate lipase inhibitor formulations
|
US20080305161A1
(en)
*
|
2005-04-13 |
2008-12-11 |
Pfizer Inc |
Injectable depot formulations and methods for providing sustained release of nanoparticle compositions
|
CN101166514A
(zh)
*
|
2005-04-13 |
2008-04-23 |
辉瑞产品公司 |
用于提供持续释放的纳米粒组合物的可注射储库制剂及方法
|
CA2603189A1
(fr)
*
|
2005-04-13 |
2006-10-19 |
Pfizer Products Inc. |
Formulations de depot injectables et procedes destines a assurer une liberation prolongee de medicaments peu solubles comprenant des nanoparticules
|
WO2006132752A1
(fr)
*
|
2005-05-10 |
2006-12-14 |
Elan Pharma International Limited |
Compositions nanoparticulaires a liberation regulee comprenant de la vitamine k2
|
CN101212954A
(zh)
*
|
2005-05-10 |
2008-07-02 |
伊兰制药国际有限公司 |
纳米粒氯吡格雷制剂
|
US20100028439A1
(en)
*
|
2005-05-23 |
2010-02-04 |
Elan Pharma International Limited |
Nanoparticulate stabilized anti-hypertensive compositions
|
EA201100022A1
(ru)
*
|
2005-06-03 |
2011-06-30 |
Элан Фарма Интернэшнл Лтд. |
Способ получения композиции наночастиц мезилата иматиниба
|
CA2610480A1
(fr)
*
|
2005-06-03 |
2007-05-10 |
Scott Jenkins |
Preparations nanoparticulaires a base d'acetaminophene
|
US20070042049A1
(en)
*
|
2005-06-03 |
2007-02-22 |
Elan Pharma International, Limited |
Nanoparticulate benidipine compositions
|
JP2009517485A
(ja)
|
2005-06-08 |
2009-04-30 |
エラン・ファルマ・インターナショナル・リミテッド |
セフジトレンを含むナノ粒子状および制御放出組成物
|
ATE446742T1
(de)
*
|
2005-06-09 |
2009-11-15 |
Elan Pharma Int Ltd |
Nanopartikuläre ebastinformulierungen
|
MX2007015882A
(es)
*
|
2005-06-13 |
2008-03-04 |
Elan Pharma Int Ltd |
Formulaciones en combinacion nanoparticulada de clopidogrel y aspirina.
|
CA2612384A1
(fr)
*
|
2005-06-15 |
2006-12-28 |
Elan Pharma International, Limited |
Formulations d'azelnidipine nanoparticulaire
|
EP1904041A2
(fr)
*
|
2005-07-07 |
2008-04-02 |
Elan Pharma International Limited |
Formulations de clarithromycine nanoparticulaires
|
MX2008001919A
(es)
*
|
2005-08-12 |
2008-03-24 |
Astrazeneca Ab |
Proceso para la preparacion de una dispersion estable de particulas submicronicas en un medio acuoso.
|
WO2007029660A1
(fr)
*
|
2005-09-06 |
2007-03-15 |
Astellas Pharma Inc. |
Microparticule de substance à peine soluble ayant un matériau de base entérique adsorbé à la surface de la substance
|
CA2622200A1
(fr)
*
|
2005-09-13 |
2007-03-22 |
Elan Pharma International, Limited |
Formulations nanoparticulaires de tadalafil
|
JP2009508859A
(ja)
*
|
2005-09-15 |
2009-03-05 |
エラン ファーマ インターナショナル リミテッド |
ナノ粒子アリピプラゾール製剤
|
US20070077309A1
(en)
*
|
2005-09-30 |
2007-04-05 |
Wong Patrick S |
Banded controlled release nanoparticle active agent formulation dosage forms and methods
|
KR101405545B1
(ko)
*
|
2005-11-28 |
2014-07-03 |
마리누스 파마슈티컬스 |
ganaxolone 제형, 이의 제조방법 및 용도
|
MX2008009032A
(es)
|
2006-01-12 |
2008-09-26 |
Univ Arkansas |
Composiciones de nanoparticulas y metodos para fabricarlas y utilizarlas.
|
US10100266B2
(en)
|
2006-01-12 |
2018-10-16 |
The Board Of Trustees Of The University Of Arkansas |
Dielectric nanolubricant compositions
|
US8367112B2
(en)
*
|
2006-02-28 |
2013-02-05 |
Alkermes Pharma Ireland Limited |
Nanoparticulate carverdilol formulations
|
US10137083B2
(en)
|
2006-03-07 |
2018-11-27 |
SGN Nanopharma Inc |
Ophthalmic preparations
|
US11311477B2
(en)
|
2006-03-07 |
2022-04-26 |
Sgn Nanopharma Inc. |
Ophthalmic preparations
|
AU2007224006A1
(en)
*
|
2006-03-07 |
2007-09-13 |
Novavax, Inc. |
Nanoemulsions of poorly soluble pharmaceutical active ingredients and methods of making the same
|
US20080166411A1
(en)
*
|
2006-04-10 |
2008-07-10 |
Pfizer Inc |
Injectable Depot Formulations And Methods For Providing Sustained Release Of Poorly Soluble Drugs Comprising Nanoparticles
|
MX2008015275A
(es)
*
|
2006-05-30 |
2009-02-06 |
Elan Pharma Int Ltd |
Formulaciones de posaconazol en nanoparticulas.
|
RU2009102262A
(ru)
*
|
2006-06-26 |
2010-08-10 |
Мьючуал Фармасьютикал Компани, Инк. (Us) |
Композиции активного агента, способы их получения и способы применения
|
US20080213374A1
(en)
*
|
2006-07-10 |
2008-09-04 |
Elan Pharma International Limited |
Nanoparticulate sorafenib formulations
|
AU2007272501A1
(en)
*
|
2006-07-12 |
2008-01-17 |
Elan Pharma International Limited |
Nanoparticulate formulations of modafinil
|
AU2007321357B2
(en)
|
2006-11-13 |
2012-06-14 |
Basf Se |
Application of block copolymers based on vinyl lactams and vinyl acetate as solubilizers
|
EP2101735A2
(fr)
|
2006-11-28 |
2009-09-23 |
Marinus Pharmaceuticals, Inc. |
Formulations de nanoparticules et procédés de préparation et d'utilisation de celles-ci
|
TW200848039A
(en)
*
|
2007-02-09 |
2008-12-16 |
Astrazeneca Ab |
Pharmaceutical compositions
|
WO2008097165A1
(fr)
*
|
2007-02-09 |
2008-08-14 |
Astrazeneca Ab |
Procédé de préparation d'une dispersion stable de particules submicroniques amorphes solides dans un milieu aqueux
|
WO2008135828A2
(fr)
|
2007-05-03 |
2008-11-13 |
Pfizer Products Inc. |
Nanoparticules comprenant un médicament, de l'éthylcellulose et un sel biliaire
|
WO2008135855A2
(fr)
|
2007-05-03 |
2008-11-13 |
Pfizer Products Inc. |
Nanoparticules contenant un inhibiteur de la protéine de transfert d'ester de cholestéryle et un polymère non ionisable
|
US8722736B2
(en)
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
US8426467B2
(en)
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
WO2008149192A2
(fr)
|
2007-06-04 |
2008-12-11 |
Pfizer Products Inc. |
Nanoparticules comportant un polymère cellulosique non ionisable et un copolymère bloc amphiphile non ionisable
|
US9545384B2
(en)
|
2007-06-04 |
2017-01-17 |
Bend Research, Inc. |
Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate
|
MY152789A
(en)
*
|
2007-07-31 |
2014-11-28 |
Otsuka Pharma Co Ltd |
Methods for producing aripiprazole suspension and freeze-dried formulation
|
US8486043B2
(en)
*
|
2007-10-12 |
2013-07-16 |
Map Pharmaceuticals, Inc. |
Inhalation drug delivery
|
WO2009073215A1
(fr)
|
2007-12-06 |
2009-06-11 |
Bend Research, Inc. |
Compositions pharmaceutiques comprenant des nanoparticules et une matière de remise en suspension
|
EP2240162A4
(fr)
|
2007-12-06 |
2013-10-09 |
Bend Res Inc |
Nanoparticules comprenant un polymère non ionisable et un copolymère de méthacrylate fonctionnalisé par amine
|
JP2011520779A
(ja)
*
|
2008-03-21 |
2011-07-21 |
エラン・ファルマ・インターナショナル・リミテッド |
イマチニブの部位特異的送達のための組成物および使用の方法
|
US20100159010A1
(en)
*
|
2008-12-24 |
2010-06-24 |
Mutual Pharmaceutical Company, Inc. |
Active Agent Formulations, Methods of Making, and Methods of Use
|
US20120065221A1
(en)
|
2009-02-26 |
2012-03-15 |
Theraquest Biosciences, Inc. |
Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use
|
KR20120022895A
(ko)
*
|
2009-04-09 |
2012-03-12 |
엘커메스 파마 아일랜드 리미티드 |
약물 전달 조성물
|
FR2945950A1
(fr)
|
2009-05-27 |
2010-12-03 |
Elan Pharma Int Ltd |
Compositions de nanoparticules anticancereuses et procedes pour les preparer
|
CA2763456C
(fr)
|
2009-05-27 |
2017-10-24 |
Alkermes Pharma Ireland Limited |
Reduction de l'agregation a l'origine de paillettes dans des compositions a base d'un principe actif nanoparticulaire
|
US9012511B2
(en)
|
2010-05-19 |
2015-04-21 |
Alkermes Pharma Ireland Limited |
Nanoparticulate cinacalcet compositions
|
JP2015501802A
(ja)
|
2011-11-17 |
2015-01-19 |
ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド,ア ボディー コーポレイトTHE REGENTS OF THE UNIVERSITY OF COLORADO,a body corporate |
眼への薬物送達を向上させるための方法および組成物、ならびに徐放性送達製剤
|
EP2842545B1
(fr)
|
2012-04-24 |
2020-02-12 |
Osaka University |
Procédé de production d'une dispersion aqueuse de nanoparticules de médicament et son utilisation
|
EP2847207B1
(fr)
|
2012-05-08 |
2019-03-27 |
Nicox Ophthalmics, Inc. |
Nanocristaux du propionate de fluticasone
|
US8765725B2
(en)
|
2012-05-08 |
2014-07-01 |
Aciex Therapeutics, Inc. |
Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
|
KR20150023794A
(ko)
|
2012-06-18 |
2015-03-05 |
이노바 다이나믹스, 인코포레이티드 |
용기에 보관된 나노와이어 현탁액 중의 응집체 감소
|
US9251937B2
(en)
|
2012-06-29 |
2016-02-02 |
General Electric Company |
Heat stable nanoparticle preparations and associated methods thereof
|
US9815865B2
(en)
|
2013-01-07 |
2017-11-14 |
Nicox Ophthalmics, Inc. |
Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
|
JP6336246B2
(ja)
*
|
2013-03-13 |
2018-06-06 |
大同化成工業株式会社 |
ナノ粒子化製剤及びその製造方法
|
WO2016098785A1
(fr)
|
2014-12-15 |
2016-06-23 |
エム・テクニック株式会社 |
Procédé de production de microparticules de matière organique et procédé de modification de microparticules de matière organique
|
CA2984421C
(fr)
|
2015-05-01 |
2024-04-09 |
Cocrystal Pharma, Inc. |
Analogues de nucleosides a utiliser pour le traitement d'infections par des virus de la famille des flaviviridae et du cancer
|
JP2018530585A
(ja)
|
2015-10-16 |
2018-10-18 |
マリナス ファーマシューティカルズ インコーポレイテッド |
ナノ粒子を含む注射可能な神経ステロイド製剤
|
KR102518846B1
(ko)
|
2016-08-11 |
2023-04-05 |
오비드 테라퓨틱스 인크. |
간질 장애의 치료를 위한 방법 및 조성물
|
US10391105B2
(en)
|
2016-09-09 |
2019-08-27 |
Marinus Pharmaceuticals Inc. |
Methods of treating certain depressive disorders and delirium tremens
|
US11266662B2
(en)
|
2018-12-07 |
2022-03-08 |
Marinus Pharmaceuticals, Inc. |
Ganaxolone for use in prophylaxis and treatment of postpartum depression
|
MX2022001553A
(es)
|
2019-08-05 |
2022-04-18 |
Marinus Pharmaceuticals Inc |
Ganaxolona para su uso en el tratamiento del estado epileptico.
|
MX2022006014A
(es)
|
2019-12-06 |
2022-06-22 |
Marinus Pharmaceuticals Inc |
Ganaxolona para uso en el tratamiento del complejo de esclerosis tuberosa.
|
US11499081B2
(en)
*
|
2020-08-04 |
2022-11-15 |
Baker Hughes Oilfield Operations Llc |
Stabilized water-dispersible latex additives for drilling fluids
|